ACAD

ACADIA PHARMACEUTICALS INC

NasdaqGS · Healthcare

$26.20

+1.67% today

last filing 2026-06-26Pro sees filings in ~15 min

Price

hover · 4 moves explained

10 sells

Analyst consensus

Buy

$32.30target+23.3%vs $26.20 today

$17.00 low today target$45.00 high

20 analysts · ~12-month consensus · as of Jul 7. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25+15.3%

$0.16

exp $0.14

Q3 '25

$0.42

exp $0.15

Q4 '25-4.2%

$0.14

exp $0.14

Q1 '26-75.2%

$0.02

exp $0.08

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-06-29	Kihara James	PRINCIPAL ACCOUNTING OFFICER	—Direct	11,421	$26.08	$297.9K
Grant	2026-06-02	BAKER BROS. ADVISORS LP	10% owner	—Indirect	18,622	—	—
Grant	2026-06-02	BAKER BROS. ADVISORS LP	10% owner	—Indirect	18,622	—	—
Exercise	2026-06-01	HARRIGAN EDMUND	Director	—Direct	8,107	—	—
Exercise	2026-06-01	Ndu Adora	Director	—Direct	8,107	—	—

Sell

Kihara James

PRINCIPAL ACCOUNTING OFFICER · 2026-06-29

$297.9K

11,421 @ $26.08

Grant

BAKER BROS. ADVISORS LP

10% owner · 2026-06-02

—

18,622 shares

Grant

BAKER BROS. ADVISORS LP

10% owner · 2026-06-02

—

18,622 shares

Exercise

HARRIGAN EDMUND

Director · 2026-06-01

—

8,107 shares

Exercise

Ndu Adora

Director · 2026-06-01

—

8,107 shares

27 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →